Equity Analysis

Quarterly Results

    Aurobindo Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524804
    INE406A01037
    335.4746309
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    AUROPHARMA
    34.09
    65358.52
    EPS(TTM)
    Face Value()
    Div & Yield %:
    32.72
    1
    0.4
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales2883.562757.882425.22
Other Operating Income33.0766.7134.87
Other Income 54.26122.6665.32
Total Income2970.892947.252525.41
Total Expenditure 2203.482103.711961.16
PBIDT767.41843.54564.25
Interest 66.1951.6351.13
PBDT701.22791.91513.12
Depreciation68.2868.1666.88
Tax164.03188.43119.66
Fringe Benefit Tax0.000.000.00
Deferred Tax-3.14-2.21-2.46
Reported Profit After Tax472.05537.53329.04
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item472.05537.53329.04
EPS (Unit Curr.)8.139.215.62
EPS (Adj) (Unit Curr.)8.139.215.62
Calculated EPS (Unit Curr.)8.139.255.62
Calculated EPS (Adj) (Unit Curr.)8.139.255.62
Calculated EPS (Ann.) (Unit Curr.)32.5137.0222.46
Calculated EPS (Adj) (Ann.) (Unit Curr.)32.5137.0222.46
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity58.0858.0858.59
Reserve & Surplus0.0019598.160.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)26.6130.5923.27
PBDTM(%)24.3228.7121.16
PATM(%)16.3719.4913.57
Dividend Per Share(Rs)0.000.000.00
Diluted EPS8.139.215.62